Literature DB >> 19122149

Stromal growth and epithelial cell proliferation in ventral prostates of liver X receptor knockout mice.

Hyun-Jin Kim1, Leif C Andersson, Didier Bouton, Margaret Warner, Jan-Ake Gustafsson.   

Abstract

With specific liver X receptor alpha and beta (LXRalpha and LXRbeta) antibodies, we found that LXRalpha is strongly expressed in the luminal and basal cells of prostatic epithelium. The ventral prostates (VP) of LXRalpha(-/-) mice are characterized by the presence of smooth-muscle actin-positive stromal overgrowth around the prostatic ducts and by numerous fibrous nodules pushing into the ducts and causing obstruction, so that most of the ducts were extremely dilated. BrdU labeling and Ki67 staining revealed epithelial and stromal proliferation in the fibrous nodules. However, the dense stroma surrounding the ducts was not positive for proliferation markers. There was no detectable difference between WT and LXRalpha(-/-) mice VP in the expression of the androgen receptor, but there was an increase in nuclear expression of Snail and Smad 2/3, indicating enhanced TGF-beta signaling. Upon treatment of WT mice for 3 months with the LXR agonist T2320 or for 3 weeks with beta-sitosterol, LXRalpha was downregulated, and a VP phenotype similar to that of LXRalpha(-/-) mice resulted. We conclude that in rodents, LXRalpha seems to control VP stromal growth and that LXRalpha(-/-) mice may be a useful model to study prostatic stromal hyperplasia. Because LXRalpha is expressed in the epithelium, the excessive stromal growth in LXRalpha(-/-) mice indicates that LXRalpha is essential for epithelial stromal communication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19122149      PMCID: PMC2626742          DOI: 10.1073/pnas.0811295106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  Molecular and cellular pathogenesis of benign prostatic hyperplasia.

Authors:  Keith L Lee; Donna M Peehl
Journal:  J Urol       Date:  2004-11       Impact factor: 7.450

2.  Pancreatic exocrine insufficiency in LXRbeta-/- mice is associated with a reduction in aquaporin-1 expression.

Authors:  Chiara Gabbi; Hyun-Jin Kim; Kjell Hultenby; Didier Bouton; Gudrun Toresson; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-19       Impact factor: 11.205

3.  Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta.

Authors:  B A Janowski; M J Grogan; S A Jones; G B Wisely; S A Kliewer; E J Corey; D J Mangelsdorf
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

4.  Genome-wide expression profiling; a panel of mouse tissues discloses novel biological functions of liver X receptors in adrenals.

Authors:  Knut R Steffensen; Soek Ying Neo; Thomas M Stulnig; Vinsensius B Vega; Safia S Rahman; Gertrud U Schuster; Jan-Ake Gustafsson; Edison T Liu
Journal:  J Mol Endocrinol       Date:  2004-12       Impact factor: 5.098

5.  Structural characterisation of the mouse nuclear oxysterol receptor genes LXRalpha and LXRbeta.

Authors:  S Alberti; K R Steffensen; J A Gustafsson
Journal:  Gene       Date:  2000-02-08       Impact factor: 3.688

6.  Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group.

Authors:  R R Berges; J Windeler; H J Trampisch; T Senge
Journal:  Lancet       Date:  1995-06-17       Impact factor: 79.321

7.  Randomized trial of a combination of natural products (cernitin, saw palmetto, B-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH).

Authors:  H G Preuss; C Marcusen; J Regan; I W Klimberg; T A Welebir; W A Jones
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

8.  Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration.

Authors:  Ling Wang; Gertrud U Schuster; Kjell Hultenby; Qinghong Zhang; Sandra Andersson; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

9.  Saw palmetto for benign prostatic hyperplasia.

Authors:  Stephen Bent; Christopher Kane; Katsuto Shinohara; John Neuhaus; Esther S Hudes; Harley Goldberg; Andrew L Avins
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

10.  The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR.

Authors:  Ji-Young Cha; Joyce J Repa
Journal:  J Biol Chem       Date:  2006-11-14       Impact factor: 5.157

View more
  16 in total

Review 1.  Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

Authors:  Tristan M Nicholson; William A Ricke
Journal:  Differentiation       Date:  2011-05-26       Impact factor: 3.880

2.  Estrogen-dependent gallbladder carcinogenesis in LXRbeta-/- female mice.

Authors:  Chiara Gabbi; Hyun-Jin Kim; Rodrigo Barros; Marion Korach-Andrè; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

3.  Liver X receptors regulate cerebrospinal fluid production.

Authors:  Y-B Dai; W-F Wu; B Huang; Y-F Miao; S Nadarshina; M Warner; J-Å Gustafsson
Journal:  Mol Psychiatry       Date:  2015-09-01       Impact factor: 15.992

4.  Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells.

Authors:  Nicholes R Candelaria; Sridevi Addanki; Jine Zheng; Trang Nguyen-Vu; Husna Karaboga; Prasenjit Dey; Chiara Gabbi; Lise-Lotte Vedin; Ka Liu; Wanfu Wu; Philip K Jonsson; Jean Z Lin; Fei Su; Lakshmi Reddy Bollu; Sally E Hodges; Amy L McElhany; Mehdi A Issazadeh; William E Fisher; Michael M Ittmann; Knut R Steffensen; Jan-Åke Gustafsson; Chin-Yo Lin
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

5.  Chemical regulators of epithelial plasticity reveal a nuclear receptor pathway controlling myofibroblast differentiation.

Authors:  Jon M Carthy; Martin Stöter; Claudia Bellomo; Michael Vanlandewijck; Angelos Heldin; Anita Morén; Dimitris Kardassis; Timothy C Gahman; Andrew K Shiau; Marc Bickle; Marino Zerial; Carl-Henrik Heldin; Aristidis Moustakas
Journal:  Sci Rep       Date:  2016-07-19       Impact factor: 4.379

6.  Liver X receptors constrain tumor development and metastasis dissemination in PTEN-deficient prostate cancer.

Authors:  Anthony Alioui; Julie Dufour; Valerio Leoni; Anke Loregger; Martina Moeton; Luigi Iuliano; Chiara Zerbinati; Amandine Septier; Pierre Val; Allan Fouache; Vincenzo Russo; David H Volle; Jean-Marc A Lobaccaro; Noam Zelcer; Silvère Baron
Journal:  Nat Commun       Date:  2017-09-05       Impact factor: 14.919

7.  Snail mediates crosstalk between TGFβ and LXRα in hepatocellular carcinoma.

Authors:  Claudia Bellomo; Laia Caja; Isabel Fabregat; Wolfgang Mikulits; Dimitris Kardassis; Carl-Henrik Heldin; Aristidis Moustakas
Journal:  Cell Death Differ       Date:  2017-12-11       Impact factor: 15.828

8.  Liver x receptors protect from development of prostatic intra-epithelial neoplasia in mice.

Authors:  Aurélien J C Pommier; Julie Dufour; Georges Alves; Emilie Viennois; Hugues De Boussac; Amalia Trousson; David H Volle; Françoise Caira; Pierre Val; Philippe Arnaud; Jean-Marc A Lobaccaro; Silvère Baron
Journal:  PLoS Genet       Date:  2013-05-09       Impact factor: 5.917

9.  Lack of liver X receptors leads to cell proliferation in a model of mouse dorsal prostate epithelial cell.

Authors:  Julie Dufour; Aurélien Pommier; Georges Alves; Hugues De Boussac; Corinne Lours-Calet; David H Volle; Jean-Marc A Lobaccaro; Silvère Baron
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

10.  Liver X receptor reduces proliferation of human oral cancer cells by promoting cholesterol efflux via up-regulation of ABCA1 expression.

Authors:  Tetsuharu Kaneko; Chihiro Kanno; Naoki Ichikawa-Tomikawa; Korehito Kashiwagi; Nanae Yaginuma; Chihiro Ohkoshi; Mizuko Tanaka; Takashi Sugino; Tetsuya Imura; Hiroshi Hasegawa; Hideki Chiba
Journal:  Oncotarget       Date:  2015-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.